458 related articles for article (PubMed ID: 16706806)
61. [Detection of aberrant promoter CpG islands hypermethylation of GSTP1 in human primary hepatocellular carcinomas].
Wang JH; Qin Y; Li B; Sun ZL; Sun ZF; Guan QL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Sep; 36(5):686-8. PubMed ID: 16235538
[TBL] [Abstract][Full Text] [Related]
62. Epigenetic drivers of genetic alterations.
Toyota M; Suzuki H
Adv Genet; 2010; 70():309-23. PubMed ID: 20920753
[TBL] [Abstract][Full Text] [Related]
63. CpG island methylator phenotype association with upregulated telomerase activity in hepatocellular carcinoma.
Zhang C; Guo X; Jiang G; Zhang L; Yang Y; Shen F; Wu M; Wei L
Int J Cancer; 2008 Sep; 123(5):998-1004. PubMed ID: 18546260
[TBL] [Abstract][Full Text] [Related]
64. Genome-wide DNA methylation profiles in liver tissue at the precancerous stage and in hepatocellular carcinoma.
Arai E; Ushijima S; Gotoh M; Ojima H; Kosuge T; Hosoda F; Shibata T; Kondo T; Yokoi S; Imoto I; Inazawa J; Hirohashi S; Kanai Y
Int J Cancer; 2009 Dec; 125(12):2854-62. PubMed ID: 19569176
[TBL] [Abstract][Full Text] [Related]
65. Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma.
Shih YL; Shyu RY; Hsieh CB; Lai HC; Liu KY; Chu TY; Lin YW
Cancer; 2006 Aug; 107(3):579-90. PubMed ID: 16795071
[TBL] [Abstract][Full Text] [Related]
66. Fractional allelic loss in non-end-stage cirrhosis: correlations with hepatocellular carcinoma development during follow-up.
Roncalli M; Bianchi P; Grimaldi GC; Ricci D; Laghi L; Maggioni M; Opocher E; Borzio M; Coggi G
Hepatology; 2000 Apr; 31(4):846-50. PubMed ID: 10733538
[TBL] [Abstract][Full Text] [Related]
67. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
68. Epigenetic events in normal colonic mucosa surrounding colorectal cancer lesions.
Ramírez N; Bandrés E; Navarro A; Pons A; Jansa S; Moreno I; Martínez-Rodenas F; Zárate R; Bitarte N; Monzó M; García-Foncillas J
Eur J Cancer; 2008 Nov; 44(17):2689-95. PubMed ID: 18938072
[TBL] [Abstract][Full Text] [Related]
69. [Hepatocellular carcinoma: molecular biology aspects].
Blum HE
Zentralbl Chir; 1994; 119(11):759-63. PubMed ID: 7846955
[TBL] [Abstract][Full Text] [Related]
70. Comprehensive allelotyping of human hepatocellular carcinoma.
Nagai H; Pineau P; Tiollais P; Buendia MA; Dejean A
Oncogene; 1997 Jun; 14(24):2927-33. PubMed ID: 9205099
[TBL] [Abstract][Full Text] [Related]
71. CpG island hypermethylation in progression of esophageal and gastric cancer.
Sato F; Meltzer SJ
Cancer; 2006 Feb; 106(3):483-93. PubMed ID: 16362978
[TBL] [Abstract][Full Text] [Related]
72. NORE1B is a putative tumor suppressor in hepatocarcinogenesis and may act via RASSF1A.
Macheiner D; Gauglhofer C; Rodgarkia-Dara C; Grusch M; Brachner A; Bichler C; Kandioler D; Sutterlüty H; Mikulits W; Schulte-Hermann R; Grasl-Kraupp B
Cancer Res; 2009 Jan; 69(1):235-42. PubMed ID: 19118008
[TBL] [Abstract][Full Text] [Related]
73. Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.
Lu CY; Hsieh SY; Lu YJ; Wu CS; Chen LC; Lo SJ; Wu CT; Chou MY; Huang TH; Chang YS
Genes Chromosomes Cancer; 2009 Dec; 48(12):1057-68. PubMed ID: 19760608
[TBL] [Abstract][Full Text] [Related]
74. The use of epigenetic biomarkers for preclinical detection of hepatocellular carcinoma: potential for noninvasive screening of high-risk populations.
Rivenbark AG; Coleman WB
Clin Cancer Res; 2007 Apr; 13(8):2309-12. PubMed ID: 17438087
[No Abstract] [Full Text] [Related]
75. Preneoplastic lesions in human hepatocarcinogenesis.
Libbrecht L; Desmet V; Roskams T
Liver Int; 2005 Feb; 25(1):16-27. PubMed ID: 15698394
[TBL] [Abstract][Full Text] [Related]
76. Understanding the hypercarcinogenic state in chronic hepatitis: a clue to the prevention of human hepatocellular carcinoma.
Hino O; Kajino K; Umeda T; Arakawa Y
J Gastroenterol; 2002; 37(11):883-7. PubMed ID: 12483242
[TBL] [Abstract][Full Text] [Related]
77. DNA methylation in cancer: too much, but also too little.
Ehrlich M
Oncogene; 2002 Aug; 21(35):5400-13. PubMed ID: 12154403
[TBL] [Abstract][Full Text] [Related]
78. [Molecular biology and hepatocellular carcinoma: current status and future prospects].
Saffroy R; Pham P; Lemoine A; Debuire B
Ann Biol Clin (Paris); 2004; 62(6):649-56. PubMed ID: 15563423
[TBL] [Abstract][Full Text] [Related]
79. Genetic mechanisms of hepatocarcinogenesis.
Feitelson MA; Sun B; Satiroglu Tufan NL; Liu J; Pan J; Lian Z
Oncogene; 2002 Apr; 21(16):2593-604. PubMed ID: 11971194
[TBL] [Abstract][Full Text] [Related]
80. Concerted nonsyntenic allelic losses in hyperploid hepatocellular carcinoma as determined by a high-resolution allelotype.
Boige V; Laurent-Puig P; Fouchet P; Fléjou JF; Monges G; Bedossa P; Bioulac-Sage P; Capron F; Schmitz A; Olschwang S; Thomas G
Cancer Res; 1997 May; 57(10):1986-90. PubMed ID: 9157995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
